Evidence map›Paper›PMID 32023866›Full record

ArticleInternational journal of molecular sciences2020

TiO

Yidan Wang, Allan Sauvat, Celine Lacrouts, Jérôme Lebeau, Romain Grall, Marie Hullo, Fabrice Nesslany, Sylvie Chevillard

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Titanium Dioxide: Structure, Impact, and Toxicity.International journal of environmental research and public health · 2022
    Review
  3. Counteracting Radio-Resistance Using the Optimization of Radiotherapy.International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yidan WangCommissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.
Allan SauvatGustave Roussy, Institut National de la Santé et de la Recherche Médicale, U1138, 94800 Villejuif, France.
Celine LacroutsCommissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.
Jérôme LebeauCommissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.
Romain GrallCommissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.
Marie HulloCommissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.
Fabrice NesslanyLaboratoire de Toxicologie Génétique, Institut Pasteur de Lille, Université de Lille, EA 4483, 59000 Lille, France.
Sylvie ChevillardCommissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among nanomaterials (NMs), titanium dioxide (TiO

Indexed as

BronchiolesCell LineCell ProliferationCell SurvivalHumansMetal NanoparticlesOxidative StressRadiotherapyReactive Oxygen SpeciesTitaniumReactive Oxygen SpeciesTitaniumtitanium dioxidephotocatalysisradiation sensitivityTiO2 nanoparticles

Identifiers

PMID32023866
PMCPMC7037422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.